VN July 2026

Vetnuus | July 2026 45 Veterinary Dentistry and Maxillofacial Surgery Referrals Veterinary Dentistry and Maxillofacial Clinic, Private Bag X04, Onderstepoort, 0110 Veterinary Dentistry and Maxillofacial Clinic, Onderstepoort Veterinary Academic Hospital, Faculty of Veterinary Science, University of Pretoria, Old Soutpan Road (M35), Onderstepoort, South Africa Tel: +27 (0)12 529 8276, Fax: +27 (0) 12 529 8479, e-mail: sadent@mweb.co.za, website: www.vetdentsa.co.za, Facebook: Vetdent SA Regulars I Dental Column 4. Probiotics and other neutraceuticals Probiotics and various anti-inflammatory or antioxidant nutraceuticals, including omega-3 fatty acids, co-enzyme Q10 and plant-derived extracts, are also frequently incorporated into these products. While these ingredients may exert systemic or local anti-inflammatory effects and, in some cases, influence microbial populations, the supporting evidence in veterinary dentistry remains limited.⁴ Importantly, none of these compounds address the primary aetiological factor in periodontal disease, namely plaque. Their role, if any, should therefore be regarded as supportive rather than therapeutic. B How to evaluate a product When evaluating dental supplements, practitioners need to move beyond the ingredient list and critically assess both formulation and claims. The first and most important question remains whether the product meaningfully contributes to plaque control. If it does not, its role in altering disease progression will be limited. Equally important is the distinction between preventative and therapeutic positioning. Preventative claims, such as ‘supporting oral health’ or ‘reducing tartar accumulation’, may be reasonable when supported by appropriate evidence. Therapeutic claims, however, require a much higher level of scrutiny. Phrases such as “management of diseases of the gingiva” or “for gingival conditions” are increasingly encountered in product descriptions. While these may appear subtle, they imply an effect on pathological processes and therefore move the product conceptually into the realm of medicinal claims. In the South African regulatory framework, this distinction is not merely semantic. Products registered as feeds or nutritional supplements are permitted to support or maintain health but may not claim to treat or cure disease. Claims relating to the treatment or management of disease fall within the scope of the Medicines and Related Substances Act and require formal registration supported by evidence of safety, quality and efficacy.⁵ The use of disease-associated terminology in products that are not registered as veterinary medicines is therefore, at best, ambiguous and, at worst, misleading. A further critical consideration is whether the formulation delivers an effective dose via an appropriate route. As illustrated with both seaweed-based products and chlorhexidine-containing formulations, efficacy is highly dependent on achieving sufficient exposure at the site of action. Without clarity on dose and delivery, it becomes impossible to meaningfully relate a commercial product to published evidence. From a practical standpoint, this places a clear responsibility on the practitioner. It is necessary to critically evaluate formulations rather than accept ingredient lists at face value, to understand the importance of dose and delivery in determining efficacy, and to guide clients toward interventions that are supported by evidence. This does not preclude the use of adjunctive products, but it does require that they are positioned appropriately within a broader dental care strategy. C Clinical reality and conclusion In clinical practice, most dental supplements may offer limited benefits. They may improve oral malodour, modestly slow calculus accumulation and provide some adjunctive support in maintaining oral health. However, they do not replace tooth brushing, they do not obviate the need for professional dental cleaning, and they do not treat periodontal disease. Perhaps the greatest concern is that their use may create a false sense of security, leading to delays in appropriate diagnosis and intervention. The increasing availability of these products reflects a genuine demand for practical oral care solutions. As veterinarians, our responsibility is not to dismiss them outright, but to interpret them within the framework of evidence-based dentistry and to communicate their limitations clearly and professionally. In this context, the following is the position of the authors: In South Africa, products that claim to treat or manage disease must be registered as veterinary medicines under the Medicines Act. Products registered as feeds or supplements may not claim to treat or cure disease and must limit claims to nutritional or supportive functions. The use of wording referring to diseases of the gingiva in a non-registered product is therefore legally questionable and not aligned with the intent of the legislation. v D References 1. Niemiec BA. Periodontal disease. Top Companion Anim Med. 2008;23(2):72–80. 2. Gawor J, Jank M. Ascophyllum nodosum as a nutrient supporting oral health in dogs and cats: a review. Pol J Vet Sci. 2023;26(3):335– 342. doi:10.24425/pjvs.2023.145053. 3. Jones CG. Chlorhexidine: Is it still the gold standard? Periodontol 2000. 1997;15:55–62. 4. Hennet PR. Effectiveness of a dental gel to reduce plaque in dogs. J Vet Dent. 2002;19(1):11–14. 5. Republic of South Africa. Medicines and Related Substances Act 101 of 1965.

RkJQdWJsaXNoZXIy OTc5MDU=